期刊文献+

白血病骨髓基质细胞黏附对Jurkat细胞周期及调控的影响 被引量:1

Effects of adhesion mediated by bone marrow stroma cells from leukemia patient on cell cycle of Jurkat cells
原文传递
导出
摘要 目的观察白血病骨髓基质细胞-Jurkat细胞共培养模型中Jurkat细胞的化疗敏感性,探讨基质细胞黏附对Jurkat细胞周期及其调控蛋白表达的影响。方法常规分离、培养骨髓基质细胞,Jurkat细胞与^60Co照射的基质细胞层黏附培养,构建基质细胞-Jurkat细胞共培养模型,扫描电镜观察,通过MTT法测定Jurkat细胞DNR的IC50,流式细胞仪检测Jurkat细胞周期分布,Westernblot检测黏附培养4、24和48h Jurkat细胞周期调控蛋白cyclin A、cyclin E及p27的表达。结果悬浮培养Jurkat细胞的IC50为0.45μmol/L,而白血病基质细胞及正常基质细胞黏附组IC50分别为2.30μmol/L和1.78μmol/L。Jurkat细胞与基质细胞黏附培养24h,Go—G1期细胞的比例明显升高(48.74%±8.77%),与悬浮对照组(27.83%±1.86%)比较差异有统计学意义P〈0.01,G2-M期细胞比例明显降低为2.01%±1.17%,与悬浮对照组(20.33%±1.84%)比较差异有统计学意义P〈0.01;Western Blot检测发现cyclin A、cyclin E的表达在Jurkat细胞黏附培养4h时即有所下调,24h和48h尤为明显,而p27的表达则出现上调,以48h最为明显。结论白血病基质细胞黏附能介导白血病细胞耐药,其机制可能与白血病细胞周期改变有关。 Objective To investigate the effects of adhesion mediated by bone marrow stmma cells from leukemia patient on chemotherapeutics sensitivity and cell cycle of Jurkat ceils in the co-cultured model. Methods Bone marrow stroma cells were isolated and cultured from leukemia patients routinely. To construct the co-cultured model, Jurkat cells were co-cultured with BMSCs the irradiated layer by 60Co, and the model was observed with scanning electron microscope. The IC50 values of Jurkat cells exposured to DNR were quantified by MTT. The cell cycles of Jurkat cells after 24h-adhesion in the co-cultured model were analyzed by FACS. The expression of cyclin A, cyclin E and p27 in Jurkat cells adhered to BMSCs for 4h, 24h and 48h were detected by Western blot. Results Jurkat cells in the co-cultured model showed a decreased sensitivity to DNR, IC50 values for normal BMSCs, leukemic BMSCs and non -adhered control were of 1. 78μmol/L,2. 30μmol/L and 0. 45μmoL/L, respectively. The percentages of G0-G1 phase for leukemic BMSCs group and non - adhered control group were of 48.74% ± 8.77% and 27.83% ±1.86% , respectively. The percentages of G2-M phase for leukemic BMSCs group and non -adhered control group were of 2. 01% ±1.17% and 20. 33% ±1.84%, respectively. Compared with control group, the 24h-adhesion mediated by BMSCs from leukemia patients up-regulated the percentage of G0-G1 phase of Jurkat cells ( P 〈0. 01 ), but down-regulated the percentage of G2-M phase ( P 〈 0. 01 ). The expression of cyclin A and cyclin E in Jurkat cells was up-regulated when adhered to BMSCs for four hours and the higher expression emerged after adhering for 24h and 48h. Oppositely, the expression of p27 were down-regulated, especially after 48h-adhesion. Conclusions Drug resistance of leukemia cells can be mediated by adhering to bone marrow stroma cells, which may be related to the changes of cell cycle.
出处 《中国医师杂志》 CAS 2009年第1期50-53,共4页 Journal of Chinese Physician
关键词 白血病 骨髓细胞 细胞黏附 细胞周期 细胞周期蛋白质类 抗药性 肿瘤 Leukemia Bone marrow cells Cell adhesion Cell cycle Cell cycle proteins Drug resistance,neoplasm
  • 相关文献

参考文献10

  • 1Hartmann TN, Burger JA, Glodek A, et al. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene, 2005,24 (27) :4462-4471.
  • 2Hazlehurst LA, Argilagos RF, Emmons M, et aJ. Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells. Cancer Res,2006,66 (4) :2338-2345.
  • 3Anderson K-C. Targeted therapy of multiple myeloma based upon tumormicroenvironmental interactions. Exp-Hematol, 2007,35 ( 4 Suppl 1 ) : 155-162.
  • 4Li ZW, Dalton WS. Tumor microenvironment and drug resistance in hematologic malignancies. Blood-Rev,2006,20 ( 6 ) : 333-342.
  • 5王吉刚,梁后杰,史曦凯,陈洁平,张翼军,夏顺中,罗高兴.腺病毒介导CTLA4Ig基因在骨髓基质细胞中的表达[J].中华血液学杂志,2003,24(12):661-663. 被引量:6
  • 6金冬雁,黎孟枫译.《分子克隆实验指南》.北京:科学出版社,1998:888-897.
  • 7Konopleva M, Konoplev S, Hu W, et al. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia, 2002,16(9) : 1713-1724.
  • 8Nefedova Y, Landowski TH, Dalton WS. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia,2003,17 ( 6 ) : 1175-1182.
  • 9Matsunaga T , Takemoto N , Sato T , et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med,2003,9 (9) : 1158-1165.
  • 10Mudry RE, Fortney JE, York T, et al. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood , 2000, 96 (5) : 1926-1932.

共引文献5

同被引文献9

  • 1Castagnetti F,Palandri F,Amabile M,et al.Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase:a phase 2 trial of the GIME-MA CML Working Party[J].Blood,2009,113 (15):3428-3434.
  • 2Lee F,Fandi A,Voi M.Overcoming kinase resistance in chronic myeloid leukemia[J].Int J Biochem Cell Biol,2008,40 (3):334-343.
  • 3Schraufstatter IU,Discipio RG,Khaldoyanidi S.Mesenchymal stem cells and their microenvironment[J].Front Biosci (Landmark Ed),2011,16:2271-2288.
  • 4Funayama K,Murai F,Shimane M,et al.Adhesion-induced drug resistance in leukemia stem cells[J].Pharmacology,2010,86(2):79-84.
  • 5Chen Y,Jacamo R,Konopleva M,et al.CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia[J].J Clin Invest,2013,123 (6):2395-2407.
  • 6Weisberg E,Liu Q,Zhang X,et al.Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells[J].PLoS One,2013,8(2):e56473.
  • 7Seke Etet PF,Vecchio L,Nwabo Kamdje AH.Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance:key role of stromal microenvironment[J].Cell Signal,2012,24 (9):1883-1888.
  • 8Martín-Henao GA,Quiroga R,Sureda A,et al.L-selectin expression is low on CD34 + cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression[J].Haematologica,2000,85 (2):139-146.
  • 9Tabe Y,Jin L,Iwabuchi K,et al.Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts[J].Leukemia,2012,26 (5):883-892.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部